Gene · 6708
NIH grants1,200
NIH grants whose papers are about the gene, through NIH's grant-paper links.
881 to 900 of 1,200
Download this page as JSON| Grant | Title | SPTA1 papers | Newest fiscal year |
|---|---|---|---|
| UC2HL102923 | ARRA - NHLBI Lung Cohorts Sequencing Project | 1 | 2010 |
| UC2HL102924 | WHI Sequencing Project (WHISP) | 1 | 2010 |
| UC2HL102925 | Comprehensive Sequencing and Analysis of Variation in NHLBI Cohorts | 1 | 2010 |
| UC2HL102926 | Northwest Genomics Center | 1 | 2010 |
| UC2HL103010 | Human Exome Sequencing in Six Well-Phenotyped NHLBI Cohorts | 1 | 2010 |
| ZIAHG200340 | Gene Therapy for Hemoglobin Disorders | 1 | 2010 |
| R01GM068621 | Assembly of Spectrin Isoforms | 7 | 2009 |
| R01HL024415 | Beta-globin Transcriptional Regulation | 4 | 2009 |
| R01GM074832 | Novel Druggable Exosites in Protein Kinases | 3 | 2009 |
| U01HG004402 | GWA for Gene-Environment Interaction Effects Influencing CHD | 3 | 2009 |
| R01AI013509 | Cellular and Structural Studies of Myeloma Mutants | 2 | 2009 |
| R01HL087652 | WGA Study to Identify Genetic Variants Associated with CV Events in CHS | 2 | 2009 |
| K01MH072866 | BIOINFORMATICS TO DISCOVER GENES IN PSYCHIATRIC ILLNESS | 1 | 2009 |
| K12RR023250 | Clinical Research Career Development (RMI) | 1 | 2009 |
| K99CA133244 | Cyclin E: Implications for targeted therapy in HER2-overexpressing breast cancer | 1 | 2009 |
| K99DA023694 | The Neurotransmitter: Sodium Symporter Permeation Pathway | 1 | 2009 |
| P01DK058327 | Recombinant AAV for Correctional Genetic Abnormalities Project 4: Strategies for | 1 | 2009 |
| P50CA116199 | UTMDACC SPORE in Breast Cancer | 1 | 2009 |
| R01CA118708 | Modification of tamoxifen effectiveness by gene polymorphisms and other drugs | 1 | 2009 |
| R01DK067530 | Substrate requirements of the bile acid transporter | 1 | 2009 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/grants?page=45